30/03/2023 | Annual report 2022 |
22/03/2023 | Health economic model identifies GCAL® as a cost-effective biomarker |
17/03/2023 | Financial calendar |
16/02/2023 | Fourth quarter and full year 2022 report |
15/02/2023 | New study addresses the use of plasma calprotectin in sepsis management |